Advances in Urate-Lowering Therapy: Time to Revisit High-Dose Febuxostat

Am J Ther. 2017 May;24(3):e241-e242. doi: 10.1097/MJT.0000000000000565.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Approval
  • Drug Therapy, Combination
  • Febuxostat / therapeutic use*
  • Gout / drug therapy*
  • Gout Suppressants / therapeutic use*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Gout Suppressants
  • Febuxostat